Biography: Yan Shi, MD
Certifications & Memberships
- Surgery - American Board of Surgery
Education
Fellowship | Pediatric Surgery
Pediatric Surgery - Cohen Children's Medical Center - Northwell Health (2018 - 2020)
Residency | General Surgery
General Surgery - Baylor College Of Medicine - Texas Medical Center (2011 - 2018)
Medical Education
University Of Arkansas For Medical Sciences (College of Medicine) (2011)
Undergraduate
University Of Maryland, College Park (2006)
About
Yan Shi, MD, is a pediatric surgeon in the Division of Pediatric Surgery/General and Thoracic Surgery at University Hospitals Rainbow Babies & Children’s Hospital. Board-certified in general surgery, his clinical interests include pediatric surgical oncology, thoracic wall deformities (Nuss procedure), congenital malformations, pilonidal disease, lung lesions and minimally invasive surgery.
An avid researcher, Dr. Shi has written several academic papers on topics relating to pediatric malignant tumors and oncology surgery and treatment of solid pediatric tumors and has published several studies related to the treatment of malignant tumors in children. His research interests center on improving clinical outcomes for pediatric oncology surgery.
After earning his undergraduate degree in cell biology and molecular genetics from the University of Maryland, College Park, Dr. Shi went on to earn a medical doctorate from the University of Arkansas for Medical Sciences followed by a residency in general surgery at Baylor College of Medicine in Houston. During his residency, he completed a fellowship in pediatric surgical oncology research at Baylor College of Medicine/Texas Children’s Hospital. After his residency training, Dr. Shi completed a fellowship in pediatric surgery at Cohen Children’s Medical Center/Northwell Health, Hyde Park, New York.
Dr. Shi maintains active membership in the American College of Surgeons, American Medical Association, American Pediatric Surgical Association and the American Academy of Pediatrics.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Yan Shi did not disclose any Outside Relationships with Industry.